EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 52022XC1103(03)
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006, p. 1.)) (Text with EEA relevance) 2022/C 420/06
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006, p. 1.)) (Text with EEA relevance) 2022/C 420/06
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006, p. 1.)) (Text with EEA relevance) 2022/C 420/06
C/2022/7512
OJ C 420, 3.11.2022, p. 7–8
(BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
3.11.2022 |
EN |
Official Journal of the European Union |
C 420/7 |
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1))
(Text with EEA relevance)
(2022/C 420/06)
Decision granting an authorisation
|
Reference of the decision (2) |
Date of decision |
Substance name |
Holder(s) of the authorisation |
Authorisation number |
Authorised use |
Date of expiry of review period |
Reasons for the decision |
|
C(2022) 7512 |
27 October 2022 |
4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO) EC No: -, CAS No:- |
Zoetis Belgium S.A., Rue Laid Burniat 1, 1348 Louvain-La-Neuve, Belgium |
REACH/22/41/0 |
Industrial use as a surfactant in a lysis buffer for the release of proteins and antigens from biological material used in the manufacture of three SERELISA veterinary in vitro diagnostic devices for detecting infectious disease in farm animals |
4 January 2031 |
In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the uses of the substance and there are no suitable alternative substances or technologies. |
|
Delpharm Biotech, 2 Rue Alexander Fleming, 69366 Lyon, France |
REACH/22/41/1 |
||||||
|
Zoetis Belgium S.A. |
REACH/22/41/2 |
Industrial use in formulation of kits, kit reagents and buffer solutions in two WITNESS and three SERELISA veterinary in vitro diagnostic devices used for detecting certain diseases in pets and farm animals |
|||||
|
Delpharm Biotech |
REACH/22/41/3 |
||||||
|
Zoetis Belgium S.A. |
REACH/22/41/4 |
Professional use as a surfactant in kits, kit reagents and buffer solutions in 18 veterinary in vitro diagnostic devices including one SERELISA, six ProFLOK, six WITNESS and five VetScan, in diagnostic laboratories and veterinary clinics for detecting certain diseases in pets and farm animals |
4 January 2033 |
||||
|
REACH/22/41/5 |
Industrial use as a viral inactivating agent in the manufacture of two veterinary biologic drugs for treatment of osteoarthritis in cats and dogs |
(1) OJ L 396, 30.12.2006, p. 1.
(2) The decision is available on the European Commission website at: Authorisation (europa.eu).